FIELD R 

 Column 53 



TIME OF TREATMENT 

 RELATIVE TO: 



(1) INOCULATION 



(2) TUMOR IMPLANTATION 



(3) SENSITIZATION 



(4) INCITATION OF NON- 



INFECTIOUS PATHOLOGY 



Administration of the test compound occurs (single dose) or begins (multiple or continuous 

 dose[s]): 



1 at the same time as infection, tumor implantation, inoculation, sensitization, or initiation 

 of a test. (This includes any time up to [but not including] one hour after infection, etc. ) 



2 1 thru 24 hours after Infection, etc. 



3 >24 thru 48 hours after infection, etc. 



4 >2 thru 3 days after infection, etc. 



5 > 3 thru 4 days after infection, etc. 



6 >4 thru 5 days after infection, etc. 



7 > 5 thru 6 days after infection, etc. 



8 >6 thru 7 days after infection, etc. 



9 >7 thru 8 days after infection, etc. 

 A >8 days after infection, etc. 



B after infection, etc. , but time not specified in the data. 



Administration of the test compound is discontinued after infection and occurs (single dose) 

 or ends (multiple or continuous dose[s]): 



1 at the same time as infection, tumor implantation, inoculation, sensitization, or initiation 

 of a test. (This includes any time up to [but not including] one hour before infection, etc. ) 



C 1 thru 24 hours prior to infection, etc. 



D >24 thru 48 hours prior to infection, etc. 



E >2 thru 3 days prior to infection, etc. 



F >3 thru 4 days prior to infection, etc. 



G >4 thru 5 days prior to Infection, etc. 



H > 5 thru 6 days prior to infection, etc. 



I >6 thru 7 days prior to infection, etc. 



J >7 thru 8 days prior to infection, etc. 



K >8 days prior to infection, etc. 



L prior to infection, etc. , but time not specified in the data. 



Administration of the compound occurs or begins: 



M prior to infection and continues after infection, etc. (The time prior to and after infection is 



not further considered with this symbol. ) 



135 



